Molecular studies demonstrated that the majority of ALCL cases have abnormal expression of the anaplastic lymphoma kinase (ALK) oncogene due to chromosomal translocation t(2;5)(p23;q35), which is a key pathogenic factor for ALCL development. This evidence concerns the gene ALK and anaplastic large cell lymphoma.